XOMA Royalty Corporation (XOMA) - Total Assets
Based on the latest financial reports, XOMA Royalty Corporation (XOMA) holds total assets worth $271.86 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of XOMA Royalty Corporation to assess how comfortably operating cash covers total debt obligations.
XOMA Royalty Corporation - Total Assets Trend (1985–2025)
This chart illustrates how XOMA Royalty Corporation's total assets have evolved over time, based on quarterly financial data. See XOMA net asset value for net asset value and shareholders' equity analysis.
XOMA Royalty Corporation - Asset Composition Analysis
Current Asset Composition (December 2025)
XOMA Royalty Corporation's total assets of $271.86 Million consist of 43.0% current assets and 57.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 30.4% |
| Accounts Receivable | $4.90 Million | 1.8% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $44.76 Million | 16.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1985–2025)
This chart illustrates how XOMA Royalty Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see XOMA market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: XOMA Royalty Corporation's current assets represent 43.0% of total assets in 2025, a decrease from 60.4% in 1985.
- Cash Position: Cash and equivalents constituted 30.4% of total assets in 2025, down from 57.1% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 0.0% in 1985.
- Asset Diversification: The largest asset category is intangible assets at 16.4% of total assets.
XOMA Royalty Corporation Competitors by Total Assets
Key competitors of XOMA Royalty Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX
|
USA | $8.68 Billion |
|
Abivax SA
PA:ABVX
|
France | €584.34 Million |
|
Genscript Biotech Corporation
F:G51
|
Germany | €4.85 Billion |
|
Zealand Pharma A/S
CO:ZEAL
|
Denmark | Dkr16.46 Billion |
|
ZAI LAB LTD0000006
F:1ZLB
|
Germany | €1.10 Billion |
|
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
|
China | CN¥4.48 Billion |
|
Galapagos N.V.
AS:GLPG
|
Netherlands | €3.37 Billion |
|
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513
|
China | CN¥3.78 Billion |
XOMA Royalty Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.59 | 5.54 | 13.88 |
| Quick Ratio | 3.59 | 5.54 | 13.11 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $85.67 Million | $92.79 Million | $80.96 Million |
XOMA Royalty Corporation - Advanced Valuation Insights
This section examines the relationship between XOMA Royalty Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.54 |
| Latest Market Cap to Assets Ratio | 2.71 |
| Asset Growth Rate (YoY) | 23.2% |
| Total Assets | $272.70 Million |
| Market Capitalization | $738.97 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values XOMA Royalty Corporation's assets at a significant premium (2.71x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: XOMA Royalty Corporation's assets grew by 23.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for XOMA Royalty Corporation (1985–2025)
The table below shows the annual total assets of XOMA Royalty Corporation from 1985 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $272.70 Million | +23.24% |
| 2024-12-31 | $221.28 Million | -5.56% |
| 2023-12-31 | $234.30 Million | +66.90% |
| 2022-12-31 | $140.38 Million | -15.72% |
| 2021-12-31 | $166.56 Million | +32.95% |
| 2020-12-31 | $125.28 Million | +30.88% |
| 2019-12-31 | $95.72 Million | +50.07% |
| 2018-12-31 | $63.78 Million | +41.95% |
| 2017-12-31 | $44.94 Million | +56.69% |
| 2016-12-31 | $28.68 Million | -61.70% |
| 2015-12-31 | $74.88 Million | -16.46% |
| 2014-12-31 | $89.63 Million | -33.50% |
| 2013-12-31 | $134.78 Million | +27.54% |
| 2012-12-31 | $105.68 Million | +35.42% |
| 2011-12-31 | $78.04 Million | +5.10% |
| 2010-12-31 | $74.25 Million | +40.56% |
| 2009-12-31 | $52.82 Million | -21.36% |
| 2008-12-31 | $67.17 Million | -20.80% |
| 2007-12-31 | $84.81 Million | -7.28% |
| 2006-12-31 | $91.48 Million | +26.04% |
| 2005-12-31 | $72.58 Million | +56.89% |
| 2004-12-31 | $46.26 Million | -61.08% |
| 2003-12-31 | $118.85 Million | +65.57% |
| 2002-12-31 | $71.78 Million | -16.64% |
| 2001-12-31 | $86.11 Million | +90.45% |
| 2000-12-31 | $45.21 Million | +59.76% |
| 1999-12-31 | $28.30 Million | -24.13% |
| 1998-12-31 | $37.30 Million | -42.44% |
| 1997-12-31 | $64.80 Million | +12.31% |
| 1996-12-31 | $57.70 Million | +41.08% |
| 1995-12-31 | $40.90 Million | -34.46% |
| 1994-12-31 | $62.40 Million | -33.69% |
| 1993-12-31 | $94.10 Million | -13.91% |
| 1992-12-31 | $109.30 Million | -29.16% |
| 1991-12-31 | $154.30 Million | +59.07% |
| 1990-12-31 | $97.00 Million | -12.22% |
| 1989-12-31 | $110.50 Million | +100.91% |
| 1988-12-31 | $55.00 Million | -17.29% |
| 1987-12-31 | $66.50 Million | +40.30% |
| 1986-12-31 | $47.40 Million | +218.12% |
| 1985-12-31 | $14.90 Million | -- |
About XOMA Royalty Corporation
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with co… Read more